Sens. Want Probe Into Zohydro 'Pay To Play' Meetings

Law360, Washington (March 10, 2014, 6:05 PM EDT) -- A pair of Republican senators on Monday urged a government watchdog to investigate claims that pharmaceutical companies paid to attend private meetings between the U.S. Food and Drug Administration and medical professionals to influence the approval of controversial opioid painkiller Zohydro ER.

In a letter, Sens. David Vitter, R-La., and Mike Lee, R-Utah, pressed the U.S. Department of Health and Human Services Office of Inspector General to open an investigation into “disturbing” media reports that drug companies had paid between $25,000 and $35,000 to the University...
To view the full article, register now.